Article
High metallothionein predicts poor survival in glioblastoma multiforme
22 Oct 2015
Abstract excerpt
BACKGROUND: Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor. Even with vigorous surgery, radiation and chemotherapy treatment, survival rates of GBM are very poor and predictive markers for prognosis are currently lacking. METHODS: We performed whole genome expression studies of 67 fresh frozen untreated GBM tumors and validated results by 210 GBM samples' expression data...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
